Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neurofibromatosis 1 × Lovastatin × Clear all

Phase

Status

Completed 3 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Learning Disabilities 1 Dyslexia 1

Interventions

AZD 6244 7 trametinib 4 omipalisib 1 mirdametinib 1 dabrafenib 1 Vincristine 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Lovastatin 1 Inhalation 1 Dosage Forms 1 Curcumin 1 Control Groups 1 Carboplatin 1 Biopsy 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02964884 2025-06-24

Interventions for Reading Disabilities in NF1

Vanderbilt University

Phase 2 Active not recruiting

Dyslexia, Learning Disabilities, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡